Showing 1 - 10 of 41
Persistent link: https://www.econbiz.de/10001484877
As healthcare costs are rising globally and biologic treatments are a growing segment of the cost, governments have created biosimilar regulatory pathways in attempt to lower the costs of biologics. Since biosimilars are still relatively nascent, the impact of the biosimilars from a practical...
Persistent link: https://www.econbiz.de/10014111826
Persistent link: https://www.econbiz.de/10015144161
Persistent link: https://www.econbiz.de/10001195975
We link the exploration-exploitation framework of organizational learning to a technology venture's strategic alliances and argue that the causal relationship between the venture's alliances and its new product development depends on the type of the alliance. In particular, we propose a product...
Persistent link: https://www.econbiz.de/10014029015
Persistent link: https://www.econbiz.de/10010199161
Persistent link: https://www.econbiz.de/10009754766
Examines the link between public science and thebiotechnology industry in the United States. As knowledge plays an increasingrole in our innovation-based economy, firms at the forefront of industry mustexploit their absorptive capacity, defined as the ability to recognize newinformation,...
Persistent link: https://www.econbiz.de/10013095464
How do ego-networks evolve? How does such evolution affect firms’ innovation output? This chapter uses a longitudinal sample of firms in the biotechnology industry to address these questions. We use social network theory to develop a model of the structure and dynamics of firms’...
Persistent link: https://www.econbiz.de/10015369045
Persistent link: https://www.econbiz.de/10003757403